Evidence map›Paper›PMID 26270632›Full record

ArticleJournal of the American Chemical Society2015

Systematic Evaluation of Bioorthogonal Reactions in Live Cells with Clickable HaloTag Ligands: Implications for Intracellular Imaging.

Heather E Murrey, Joshua C Judkins, Christopher W Am Ende, T Eric Ballard, Yinzhi Fang, Keith Riccardi, Li Di, Edward R Guilmette, Joel W Schwartz, Joseph M Fox and 1 more

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed.

  1. Article
  2. Development of anChemical & biomedical imaging · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Tetrazine-Inorganic chemistry frontiers · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Optimizing multifunctional fluorescent ligands for intracellular labeling.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  11. mScience China. Life sciences · 2025
    Article
  12. Article
  13. Article
  14. Review
  15. JACS Au · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Minimalist TetrazineJournal of the American Chemical Society · 2024
    Article
  20. Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Heather E MurreyWorldwide Medicinal Chemistry, Pfizer Worldwide Research and Development , Cambridge, Massachusetts 02139, United States.
Joshua C JudkinsWorldwide Medicinal Chemistry, Pfizer Worldwide Research and Development , Cambridge, Massachusetts 02139, United States.
Christopher W Am EndeWorldwide Medicinal Chemistry, Pfizer Worldwide Research and Development , Cambridge, Massachusetts 02139, United States.
T Eric BallardWorldwide Medicinal Chemistry, Pfizer Worldwide Research and Development , Cambridge, Massachusetts 02139, United States.
Yinzhi FangBrown Laboratories, Department of Chemistry and Biochemistry, University of Delaware , Newark, Delaware 19716, United States.
Keith RiccardiPharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development , Groton, Connecticut 06340, United States.
Li DiPharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development , Groton, Connecticut 06340, United States.
Edward R GuilmetteNeuroscience and Pain Research Unit, Pfizer Worldwide Research and Development , Cambridge, Massachusetts 02139, United States.
Joel W SchwartzNeuroscience and Pain Research Unit, Pfizer Worldwide Research and Development , Cambridge, Massachusetts 02139, United States.
Joseph M FoxBrown Laboratories, Department of Chemistry and Biochemistry, University of Delaware , Newark, Delaware 19716, United States.
Douglas S JohnsonWorldwide Medicinal Chemistry, Pfizer Worldwide Research and Development , Cambridge, Massachusetts 02139, United States.

Funding

This renovation project will create over 1455 sq. ft. of state- of-the-art reseaP20GM104316 · NIGMS · UNIVERSITY OF DELAWARE · PI FOX, JOSEPH M · 2014 to 2024
$26.8M
Pilot Research Subproject ProgramP30GM110758 · NIGMS · UNIVERSITY OF DELAWARE · PI BEEBE, THOMAS PAUL · 2014 to 2018
$5.8M
The Tetrazine Ligation for Efficient 18F Labeling and Pretargeted Imaging/Radiotherapy of CancerR01EB014354 · NIBIB · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FOX, JOSEPH M, LI, ZIBO · 2013 to 2016
$1.4M
Q-Exactive Orbitrap LC-MC/MS SystemS10OD016267 · OD · UNIVERSITY OF DELAWARE · PI JOHNSTON, MURRAY V · 2013 to 2013
$573k
High Performance Digital NMR SpectrometerS10RR026962 · NCRR · UNIVERSITY OF DELAWARE · PI FOX, JOSEPH M · 2010 to 2010
$500k
NCRR NIH HHS S10 RR026962NCRR NIH HHS S10RR026962-01NIBIB NIH HHS R01 EB014354NIBIB NIH HHS R01EB014354NIGMS NIH HHS P20 GM104316NIGMS NIH HHS P20GM104316NIGMS NIH HHS P30 GM110758NIGMS NIH HHS P30GM110758NIH HHS S10 OD016267NIH HHS S10OD016267-01
6 · The paper itself

Abstract

Bioorthogonal reactions, including the strain-promoted azide-alkyne cycloaddition (SPAAC) and inverse electron demand Diels-Alder (iEDDA) reactions, have become increasingly popular for live-cell imaging applications. However, the stability and reactivity of reagents has never been systematically explored in the context of a living cell. Here we report a universal, organelle-targetable system based on HaloTag protein technology for directly comparing bioorthogonal reagent reactivity, specificity, and stability using clickable HaloTag ligands in various subcellular compartments. This system enabled a detailed comparison of the bioorthogonal reactions in live cells and informed the selection of optimal reagents and conditions for live-cell imaging studies. We found that the reaction of sTCO with monosubstituted tetrazines is the fastest reaction in cells; however, both reagents have stability issues. To address this, we introduced a new variant of sTCO, Ag-sTCO, which has much improved stability and can be used directly in cells for rapid bioorthogonal reactions with tetrazines. Utilization of Ag complexes of conformationally strained trans-cyclooctenes should greatly expand their usefulness especially when paired with less reactive, more stable tetrazines.

Indexed as

Molecular ImagingAlkenesAlkynesAzidesBoron CompoundsCell SurvivalCycloaddition ReactionCyclooctanesFluoresceinFluorescent DyesHeLa CellsHumansHydrolasesIntracellular SpaceLigandsModels, Molecular4,4-difluoro-4-bora-3a,4a-diaza-s-indaceneAlkenesAlkynesAzidesBoron CompoundsCyclooctanesFluoresceinFluorescent Dyeshaloalkane dehalogenaseHydrolasesLigandsMolecular Probes

Identifiers

PMID26270632
PMCPMC4572613

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.